Chalasani N - Search Results

1

Thirty-Day Readmissions Are Largely Not Preventable in Patients With Cirrhosis.

Orman ES, Desai AP, Ghabril MS, Nephew LD, Patidar KR, Holden J, Samala NR, Gawrieh S, Vuppalanchi R, Sozio M, Lacerda M, Vilar-Gomez E, Lammert C, Liangpunsakul S, Crabb D, Masuoka H, Dakhoul L, Pan M, Gao S, Chalasani N. Orman ES, et al. Among authors: chalasani n. Am J Gastroenterol. 2024 Feb 1;119(2):287-296. doi: 10.14309/ajg.0000000000002455. Epub 2023 Sep 27. Am J Gastroenterol. 2024. PMID: 37543729

2

Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis.

Chalasani N, Gorski JC, Asghar MS, Asghar A, Foresman B, Hall SD, Crabb DW. Chalasani N, et al. Hepatology. 2003 Mar;37(3):544-50. doi: 10.1053/jhep.2003.50095. Hepatology. 2003. PMID: 12601351

3

Improved patient survival after acute variceal bleeding: a multicenter, cohort study.

Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, Pandya P, Sitaraman S, Shen J. Chalasani N, et al. Am J Gastroenterol. 2003 Mar;98(3):653-9. doi: 10.1111/j.1572-0241.2003.07294.x. Am J Gastroenterol. 2003. PMID: 12650802

4

Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis.

Chalasani N, Deeg MA, Persohn S, Crabb DW. Chalasani N, et al. Am J Gastroenterol. 2003 Aug;98(8):1849-55. doi: 10.1111/j.1572-0241.2003.07619.x. Am J Gastroenterol. 2003. PMID: 12907343

5

Predictors and implications of severe hypersplenism in patients with cirrhosis.

Liangpunsakul S, Ulmer BJ, Chalasani N. Liangpunsakul S, et al. Among authors: chalasani n. Am J Med Sci. 2003 Sep;326(3):111-6. doi: 10.1097/00000441-200309000-00001. Am J Med Sci. 2003. PMID: 14501224

6

Is hypothyroidism a risk factor for non-alcoholic steatohepatitis?

Liangpunsakul S, Chalasani N. Liangpunsakul S, et al. Among authors: chalasani n. J Clin Gastroenterol. 2003 Oct;37(4):340-3. doi: 10.1097/00004836-200310000-00014. J Clin Gastroenterol. 2003. PMID: 14506393

7

Treatment of Nonalcoholic Fatty Liver Disease.

Liangpunsakul S, Chalasani N. Liangpunsakul S, et al. Among authors: chalasani n. Curr Treat Options Gastroenterol. 2003 Dec;6(6):455-463. doi: 10.1007/s11938-003-0047-0. Curr Treat Options Gastroenterol. 2003. PMID: 14585234

8

Nurse-administered propofol versus midazolam and meperidine for upper endoscopy in cirrhotic patients.

Weston BR, Chadalawada V, Chalasani N, Kwo P, Overley CA, Symms M, Strahl E, Rex DK. Weston BR, et al. Among authors: chalasani n. Am J Gastroenterol. 2003 Nov;98(11):2440-7. doi: 10.1111/j.1572-0241.2003.08668.x. Am J Gastroenterol. 2003. PMID: 14638346 Clinical Trial.

9

Measuring the hemodynamic response to primary pharmacoprophylaxis of variceal bleeding: a cost-effectiveness analysis.

Imperiale TF, Chalasani N, Klein RW. Imperiale TF, et al. Among authors: chalasani n. Am J Gastroenterol. 2003 Dec;98(12):2742-50. doi: 10.1111/j.1572-0241.2003.08729.x. Am J Gastroenterol. 2003. PMID: 14687827

10

Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis?

Chalasani N, Crabb DW, Cummings OW, Kwo PY, Asghar A, Pandya PK, Considine RV. Chalasani N, et al. Am J Gastroenterol. 2003 Dec;98(12):2771-6. doi: 10.1111/j.1572-0241.2003.08767.x. Am J Gastroenterol. 2003. PMID: 14687831

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

556 results

Search Page